October 17-18, 2006 at the Hyatt Regency Reston Center, VA
The U.S. Food and Drug Administration (FDA) and the University of Rhode Island College of Pharmacy (URI) are co-sponsoring a conference on October 17-18, 2006 at the Hyatt Regency Reston Town Center, Reston, VA on the progress the FDA has made on the 21st Century Initiative since the final report. This event will include discussions with the Director of each CMC review Office in CDER and the Director of the Office of Testing and Research. Details of specific efforts to better meet Critical Path Industrialization goals will be provided. Read More >>>

October 30, 2006 at Henery B. Gonzalez Convention Center in San Antonio , TX
In the FDA's white paper on the critical path to development of pharmaceutical products, industrialization, or what we call pharmaceutical technology, was highlighted. The document points out that, "the pharmaceutical industry generally has been hesitant to introduce state-of-the-art science into its manufacturing processes, in part due to high in-process inventories, low factory utilization rates, significant product wastage, and compliance problems, driving up costs and decreasing productivity." Read More >>>

November 5-7, 2006 Walt Disney World in Lake Buena Vista , Florida
The ISPE Annual Meeting is your yearly opportunity to get broad exposure to the widest range of hot topics and industry issues in pharmaceutical manufacturing. Take your knowledge to the next level with in-depth sessions and workshops in your chosen field - or expose yourself to a new discipline. By picking and choosing the educational sessions that meet your needs, you'll be able to build a customized learning experience. Read More >>>

NIPTE Leadership presents Technology and Education Roadmap for Pharmaceutical Product Development and Manufacturing at the Annual Meeting of the American Institute of Chemical Engineers on November 15, 2006. Read More >>>

NIST and NIPTE co-organized a workshop on understanding the physical and mechanical properties of organic solids used in pharmaceutical formulations. We brought together participants from the pharmaceutical industry, excipient manufacturers and FDA to address the development of standards, measurement methods, property prediction methods and current best practices in the field. Read More >>>